Femasys Inc. (FEMY) Stock

Healthcare · Medical Instruments & Supplies · Member of Other US Stocks

Femasys Inc. (FEMY) closed at USD 1.74 on 2026-10-15, a change of -86.2 % over the past year, with a market capitalization of USD 13.82M.

Femasys Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Femasys Inc. key figures

Previous close

USD 1.74 (2026-10-15)

1-year change

-86.2 %

Market cap

USD 13.82M

Enterprise value

USD 17.17M

P/E ratio (trailing)

-0.50

P/E ratio (forward)

-0.78

EPS (trailing)

-3.28

EPS (forward)

-2.13

PEG ratio

n/a

Price to book

1.24

Revenue growth

-18.9 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

6.90

Employees

51

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Femasys Inc.

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Femasys Inc. and compare it with other stocks.